利奈唑胺（斯沃）——一种用于治疗多重耐药感染的新型抗菌药物 - Suppr

Suppr

超能文献

[Linezolid (Zyvox)--a novel antibacterial agent for treatments of multidrug-resistant infections].

作者信息

Blatun L A

机构信息

A.V. Vishnevsky Institute of Surgery, Russian Academy of Medical Sciences, Moscow.

出版信息

Antibiot Khimioter. 2002;47(2):38-46.

PMID:12087723

Abstract

摘要

相似文献

[Linezolid (Zyvox)--a novel antibacterial agent for treatments of multidrug-resistant infections].

Antibiot Khimioter. 2002;47(2):38-46.

[Role of linezolid in antimicrobial therapy].

Enferm Infecc Microbiol Clin. 2003 Jan;21(1):30-41. doi: 10.1016/s0213-005x(03)72872-9.

A review of linezolid: the first oxazolidinone antibiotic.

Expert Rev Anti Infect Ther. 2004 Feb;2(1):51-9. doi: 10.1586/14787210.2.1.51.

[Antimicrobial and clinical effect of linezolid (ZYVOX), new class of synthetic antibacterial drug].

Nihon Yakurigaku Zasshi. 2002 Oct;120(4):245-52. doi: 10.1254/fpj.120.245.

Linezolid, the first oxazolidinone antibacterial agent.

Ann N Y Acad Sci. 2011 Mar;1222:49-54. doi: 10.1111/j.1749-6632.2011.05962.x.

[Linezolid (Zivox), a new highly efficient antibiotic for therapy of Gram-positive infections].

Antibiot Khimioter. 2004;49(2):26-8.

Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.

Eur J Clin Microbiol Infect Dis. 2001 Jun;20(6):432-4. doi: 10.1007/pl00011286.

Linezolid breakpoints.

Clin Microbiol Infect. 2001 May;7(5):283-4. doi: 10.1046/j.1198-743x.2001.00236.x.

[Clinical significance of the antimicrobial resistance of biofilms].

Enferm Infecc Microbiol Clin. 2007 Aug-Sep;25(7):423-4. doi: 10.1157/13108704.

Have the oxazolidinones lived up to their billing? Future perspectives for this antibacterial class.

Curr Opin Investig Drugs. 2003 Feb;4(2):149-55.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Linezolid (Zyvox)--a novel antibacterial agent for treatments of multidrug-resistant infections].

Antibiot Khimioter. 2002;47(2):38-46.

[Role of linezolid in antimicrobial therapy].

Enferm Infecc Microbiol Clin. 2003 Jan;21(1):30-41. doi: 10.1016/s0213-005x(03)72872-9.

A review of linezolid: the first oxazolidinone antibiotic.

Expert Rev Anti Infect Ther. 2004 Feb;2(1):51-9. doi: 10.1586/14787210.2.1.51.

[Antimicrobial and clinical effect of linezolid (ZYVOX), new class of synthetic antibacterial drug].

Nihon Yakurigaku Zasshi. 2002 Oct;120(4):245-52. doi: 10.1254/fpj.120.245.

Linezolid, the first oxazolidinone antibacterial agent.

Ann N Y Acad Sci. 2011 Mar;1222:49-54. doi: 10.1111/j.1749-6632.2011.05962.x.

[Linezolid (Zivox), a new highly efficient antibiotic for therapy of Gram-positive infections].

Antibiot Khimioter. 2004;49(2):26-8.

Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.

Eur J Clin Microbiol Infect Dis. 2001 Jun;20(6):432-4. doi: 10.1007/pl00011286.

Linezolid breakpoints.

Clin Microbiol Infect. 2001 May;7(5):283-4. doi: 10.1046/j.1198-743x.2001.00236.x.

[Clinical significance of the antimicrobial resistance of biofilms].

Enferm Infecc Microbiol Clin. 2007 Aug-Sep;25(7):423-4. doi: 10.1157/13108704.

Have the oxazolidinones lived up to their billing? Future perspectives for this antibacterial class.

Curr Opin Investig Drugs. 2003 Feb;4(2):149-55.